Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Penumbra Inc (NY: PEN )

203.19 +10.61 (+5.51%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Penumbra Inc

< Previous 1 2 3 4 5 Next >
With Sustained Double-Digit Growth Profile, RBC Starts Coverage On This MedTech Stock
Via Benzinga
Expert Ratings for Penumbra
Over the past 3 months, 4 analysts have published their opinion on Penumbra (NYSE:PEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
JMP Analyst Names 5 Gambling Stocks To Buy On The Dip
It's been a rough year so far for casino and online gambling stocks, but one firm has identified a handful of gambling stocks that investors should consider buying on the dip. The Analyst: JMP... 
Via Benzinga
Penumbra's Return on Invested Capital Insights
Pulled from Benzinga Pro data, Penumbra (NYSE:PEN) posted Q1 earnings of $79.00 thousand, an increase from Q4 of 100.32%. Sales dropped to $203.90 million, a 0.06% decrease between quarters. 
Via Benzinga
Despite Seeing Accelerated 2023 Growth, This Analyst Cut Penumbra's Price Target - Here's Why
Via Benzinga
What 4 Analyst Ratings Have To Say About Penumbra
Analysts have provided the following ratings for Penumbra (NYSE:PEN) within the last quarter: 
Via Benzinga
Recap: Penumbra Q4 Earnings
Penumbra (NYSE:PEN) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Penumbra... 
Via Benzinga
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
Earnings Outlook For Penumbra
Penumbra (NYSE:PEN) is set to give its latest quarterly earnings report on Tuesday, 2022-02-22. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Penumbra: Q1 Earnings Insights
Penumbra (NYSE:PEN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Penumbra missed estimated earnings by... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2022
Upgrades 
Via Benzinga
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter. 
Via Benzinga
28 Biggest Movers From Yesterday
Gainers SailPoint Technologies Holdings, Inc. (NYSE: SAIL) shares jumped 29.16% to close at $64.05 on Monday after private equity firm Thoma Bravo announced plans to acquire... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth... 
Via Benzinga
Penumbra Posts Mixed Bag Q4 Results, Reports Topline Growth Of 22%
Penumbra Inc (NYSE: PEN) posted Q4 FY21 revenue of $204 million, +22.2% Y/Y (up 23% in constant currency), beating the consensus of $194.30 million. Revenue from sales... 
Via Benzinga
Penumbra's Return on Invested Capital Insights
Benzinga Pro data, Penumbra (NYSE:PEN) reported Q4 sales of $204.01 million. Earnings fell to a loss of $24.63 million, resulting in a 406.72% decrease from last quarter. In Q3,... 
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
Penumbra Weighs Combination With Shockwave Medical: Bloomberg
Penumbra Inc (NYSE: PEN) is exploring a potential deal with Shockwave Medical Inc (NASDAQ: SWAV), Bloomberg reported citing people with knowledge of the... 
Via Benzinga
CEO Of Penumbra Trades $3.9M In Company Stock
Adam Elsesser, CEO at Penumbra (NYSE:PEN), made a large buy and sell of company shares on November 11, according to a new SEC filing. What Happened: A Form 4 filing from the U.S.... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Penumbra's Thrombectomy System Shows Safety, Clinical Benefit
Penumbra Inc (NYSE: PEN) announced that the CHEETAH clinical study of its Indigo System CAT RX Catheter met the primary endpoint. As part of the Indigo Aspiration... 
Via Benzinga
Penumbra, Inc (PEN) Q3 2021 Earnings Call Transcript
PEN earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
Via Benzinga
Topics Retirement
Exposures Pension
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
Via Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Notable Penumbra Insider Trades $3.8M In Company Stock
Adam Elsesser, CEO And President at Penumbra (NYSE:PEN), made a large buy and sell of company shares on October 11, according to a new SEC filing. What Happened: A Form 4 filing... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
CEO And President Of Penumbra Trades $4.18 Million In Company Stock
Adam Elsesser, CEO And President at Penumbra (NYSE:PEN), made a large buy and sell of company shares on September 13, according to a new SEC filing. What Happened: A Form 4 filing... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
Upgrades For Signet Jewelers Ltd (NYSE: 
Via Benzinga
Penumbra Stock Registers A Healthy RS Rating
Penumbra shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81. 
Via Investor's Business Daily
Penumbra Q2 Earnings Beat Estimates; Raises FY21 Sales Outlook
Penumbra Inc (NYSE: PEN) reported Q2 sales of $184.3 million, an increase of 75.3% Y/Y, or 72.7% on a constant currency basis, beating the consensus of $170.76 million... 
Via Benzinga
Topics Earnings
Exposures Financial
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.